The protease inhibitor PI*S allele and COPD: a meta-analysis
about
SERPINA2 is a novel gene with a divergent function from SERPINA1Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin DeficiencySERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohortCausal and synthetic associations of variants in the SERPINA gene cluster with alpha1-antitrypsin serum levels.Considerations for designing a prototype genetic test for use in translational research.Alpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.Identification and characterisation of eight novel SERPINA1 Null mutationsIs PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?The prevalence of alpha-1 antitrypsin deficiency in IrelandQuantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency allelesAlpha-1-antitrypsin deficiency in Serbian adults with lung diseases.SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer.National Emphysema Treatment Trial state of the art: genetics of emphysemaMarkers of early disease and prognosis in COPD.Genetics of chronic obstructive pulmonary disease: a succinct review, future avenues and prospective clinical applications.Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research.Gene polymorphisms and chronic obstructive pulmonary disease.Emerging drugs for alpha-1-antitrypsin deficiency.The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline.PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.Genetic polymorphisms and susceptibility to lung diseaseAlpha-1 antitrypsin gene polymorphism in Chronic Obstructive Pulmonary Disease (COPD)Determination of alpha 1-antitrypsin levels and of the presence of S and Z alleles in a population of patients with chronic respiratory symptoms.Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.Alpha 1 antitrypsin distribution in an allergic asthmatic population sensitized to house dust mites
P2860
Q24297491-47460F36-46DE-4518-B10A-78068571B31BQ27348851-9876B485-5633-4DB6-AA0E-93C577408596Q28387428-931BC863-8519-4D1F-AD8E-90EA1E6F7E96Q31129874-FE2CD682-F9BA-4430-B2F2-6B4A6F4D9CA3Q33724840-5924332C-F013-44F1-A809-1760227CA4BDQ33806741-E022BE24-6A4B-4E35-9FC9-49301D0C48E4Q34295276-1C48AAAD-994E-4B0B-A028-86F5753B56A5Q34630059-37323AD5-1BC5-42E4-8BF3-5A87046C1C8FQ34997267-1968495C-370D-4278-87B8-001029C3A2A0Q35162540-45E3E889-6039-499C-82F5-BA52A302AC56Q35937953-1B0CE52F-945B-48E7-8D18-F8E9714187A9Q36353172-2AFC5A48-7E1A-4EF8-A3C5-ACFAA512D6B6Q36813713-01F79072-5B5B-4620-B412-AF08504B3743Q37103683-EB890793-E3DD-4244-BF73-D48DFED9AB3CQ37168317-E04B4953-629D-438E-ADCC-3A4CD612DAFDQ37448915-A4AFCAB7-5E33-484F-A7E0-A031600B38FFQ37553688-9337C179-6899-4D3C-AC57-E5FA4A160F93Q37562317-7AA58677-1B27-4994-9635-69DFC3AD5DA2Q37780552-23821498-E12B-49ED-9F07-DB4B5C6CA66FQ37894093-6B423B5C-50EB-4AB7-B4A9-8317C5C0C446Q38988633-3F5D0AEC-9AD7-4EBE-B15D-56D46641C46FQ39241260-BA111099-89F5-4E96-9AE1-79F654A1F1D5Q41614676-48029EA5-ABE0-4EDC-93E4-A8E2E3EADFBCQ42234561-EDD2AC2B-ABC6-488F-B3A8-4942CB13A2FAQ42414071-CF8CACF8-1358-427C-B3AF-F749DE926E10Q42592799-0F976FAA-3D4E-4E39-9224-38FC15CF26A0Q51659991-782360F2-5168-437D-AC10-2CDA0736C116Q53470982-C1F27EBD-94DC-4077-806A-10028642629DQ53580421-8002C380-DE98-4DBF-BF9C-D4A5498ADC9FQ58615946-0BC64593-F833-45E9-98A4-B88CEDDD4DB1
P2860
The protease inhibitor PI*S allele and COPD: a meta-analysis
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The protease inhibitor PI*S allele and COPD: a meta-analysis
@ast
The protease inhibitor PI*S allele and COPD: a meta-analysis
@en
The protease inhibitor PI*S allele and COPD: a meta-analysis
@nl
type
label
The protease inhibitor PI*S allele and COPD: a meta-analysis
@ast
The protease inhibitor PI*S allele and COPD: a meta-analysis
@en
The protease inhibitor PI*S allele and COPD: a meta-analysis
@nl
prefLabel
The protease inhibitor PI*S allele and COPD: a meta-analysis
@ast
The protease inhibitor PI*S allele and COPD: a meta-analysis
@en
The protease inhibitor PI*S allele and COPD: a meta-analysis
@nl
P2093
P1476
The protease inhibitor PI*S allele and COPD: a meta-analysis
@en
P2093
P356
10.1183/09031936.05.00135704
P407
P577
2005-07-01T00:00:00Z